Back to Search
Start Over
Supplementary Data from Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non–Small Cell Lung Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Data from Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non–Small Cell Lung Cancer
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....7fd3bdd182ae6ad75ba8f901111516c9
- Full Text :
- https://doi.org/10.1158/1078-0432.22440286.v1